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4What is the Pharm D course?
The Pharm D programme is a new course being offered 
by the Department of Pharmacy of the University of 
Malta in collaboration with the college of Pharmacy at the 
University of  Illinois at Chicago in chicago, UsA. This 
course was developed to provide for the rapidly growing 
niche area in pharmacy related to a professional doctorate. 
It is a means to develop professionals with a research-
oriented approach and with skills in advanced clinical 
pharmacy practice.
Pharmacists who would like to take up the area of clinical 
pharmacy as their specialisation will be able to develop 
the skills and attributes of undertaking research in the field 
while reading for a level 8 doctorate-level degree.
This course will prepare graduates who are able to deliver 
JOININg ThE PROfESSIONAL 
DOCTORATE IN PhARmACy
a significant contribution to pharmacy practice and policies 
in clinical pharmacy and applied areas.
Course Details
•	 The	 programme	 is	 delivered	 using	 a	 blended	 learning	
model that includes lectures, distance-learning and 
practice-based learning
•	 Integrate	 learning	 experience	 with	 assessment	 and	
contextualization in professional practice
•	 Course	includes	a	number	of	taught	modules	as	well	as	
clinical experience and research modules
•	 Based	 over	 three	 years	 of	 study	 covering	 a	 total	 of	 9	
semesters
•	 Successful	completion	of	90	ECTS	will	entitle	students	to	
a masters in Advanced clinical Pharmacy if they opt not 
to  proceed with the course
Want to develop your skills in advanced 
clinical pharmacy? Interested in 
furthering your studies at a Doctorate 
level? Then consider joining the 
Professional Doctorate in Pharmacy!
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Skills Developed
•	 Cooperate	and	collaborate	with	healthcare	professionals	
and patients to provide individualised treatment and 
support patient care 
•	 Manage	 medication	 knowledge,	 mitigate	 errors	 and	
support decision-making based on evidence-based 
sources, including information technology
•	 Efficiently	collect,	analyse	and	apply	required	literature	
sources for the appropriate clinical management of 
patients
•	 Evaluate,	 analyse	 and	 synthesise	 information	 and	
knowledge available to undertake and propose rational 
decisions
•	 Identify	opportunities	for	improvement	of	a	medication-
use system
•	 Collect	 and	 critically	 assess	 clinically	 relevant	 data	 to	
facilitate monitoring and management of drug therapy 
plans
•	 Contribute	 significantly	 to	 development	 of	 practice	
research
Career Prospects
The programme will empower pharmacists practising in 
the professional areas to take up leadership roles that will 
drive policies, developments in clinical practice and service 
provision which draw on a scientific and evidence base.
Contacts
Professor Lilian m. Azzopardi
Department of Pharmacy
University of malta
lilian.m.azzopardi@um.edu.mt
Tel:	(356)	21	344	971
Professor Alan Lau
college of Pharmacy
University of Illinois at chicago
alanlau@uic.edu
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AbSTRACT
ObJECTIvE To record the type and number of 
interventions made by pharmacists, to document 
intervention outcome and to record physicians’ acceptance 
of pharmacists’ recommendations.
mEThOD A retrospective study was undertaken to 
collect data about patients who received recommendations 
by pharmacists during their hospital stay at the 
Rehabilitation hospital Karin grech (RhKg). This study was 
carried out over a 12-week period. five hundred patient 
profiles were selected randomly from a sample of 1500 
profiles. Analysis of data was carried out using microsoft 
Office	Excel®	2010	and	SPSS®	Version	20.	
kEy fINDINgS Out of 500 patients, 323 (64.6%) 
received pharmacist recommendations. Out of these 
patients,	 27%	 were	 male	 (n=87)	 and	 73%	 were	 female	
(n=236),	 and	 the	 average	 age	 was	 80.3	 years.	 Patients’	
mean	 number	 of	 long	 term	medications	 was	 8.59	 with	
a median of 8. ‘Orthopaedic’ conditions were the most 
common reason for admission, representing almost 
one	 third	 of	 all	 reasons	 for	 admission	 (n=96,	 29.7%),	
followed	 by	 ‘cardiac’	 conditions	 (n=62,	 19.1%).	 A	 total	
of	 1069	 valid	 recommendations	 were	 identified	 in	
this study. ‘need for additional drug’ was the most 
common type of pharmacists’ recommendation. Of 
the	 1069	 recommendations,	 77%	 were	 accepted	 by	
physicians	 (n=823),	 19.2%	 were	 not	 accepted	 (n=212)	
and	3.5%	could	not	be	evaluated	 for	acceptance	 (n=34).	
Recommendations classified as ‘need for monitoring’ had 
the	highest	percentage	of	acceptance	(89.9%).
CONCLuSION The goal of this study was to evaluate 
the recommendations made by pharmacists in the care of 
elderly patients. Pharmacists made many recommendations 
that affect the care of hospitalised patients with the majority 
of recommendations being accepted by physicians. The 
study confirms the need for the currently offered clinical 
pharmacy service to improve patient care. 
kEyWORDS pharmacists’ recommendations, 
intervention, pharmaceutical care, elderly patients
INTRODuCTION
According to the definition by hepler and strand, 
pharmaceutical care is the responsible delivery of 
pharmacotherapy with a definite outcome aimed at 
improving the quality of life of the patient.1 Pharmaceutical 
care is based on a relationship between the patient and 
the healthcare team, who together collaborate to optimise 
medication therapy and promote patient health.
The pharmaceutical care plan is a tool used by the 
pharmacist to provide pharmaceutical care. The plan 
has two main criteria; to ensure the patient is provided 
with pharmaceutical care as needed and to document 
actions the pharmacist has taken to improve delivery 
of pharmaceutical care.2 The setting of this study was a 
rehabilitation hospital, RhKg, which is a 280-bed hospital 
that focuses on the treatment and rehabilitation of acute 
and chronic conditions in patients who are sixteen years of 
age and older.
The aims of the study were to evaluate and quantify the 
impact of pharmaceutical care interventions made by 
pharmacists at RhKg. The objectives were to record the 
type and number of interventions made by pharmacists, 
document the intervention outcomes and to record the 
physicians’ acceptance of pharmacists’ recommendations.
mEThOD
Approval from the RhKg Research committee and 
University Research Ethics committee was granted. A 
comprehensive literature review relating to pharmaceutical 
care issues, interventions, recommendations and clinical 
pharmacy services was undertaken.
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A patient profile documentation form has already been 
standardised by the pharmacists working at RhKg. The 
patient profile includes: Patient demographics, reason 
for admission, admission date, medical and drug histories 
and type of recommendations.3 There are thirteen types 
of recommendations that have been used in this study as 
outlined in Table 1.
five hundred patient profiles were randomly chosen 
from a sample of 1500 profiles and a pharmaceutical 
recommendation was identified from the patient profile 
documentation as any documented intervention made by 
pharmacists with the intent of improving patient therapy 
or quality of life, including recommendations that do not 
directly involve patient’s drug management, such as drug 
monitoring.4
A pharmaceutical recommendation was identified from 
the patient profile documentation as any documented 
intervention made by pharmacists with the intent of 
improving patient therapy or quality of life.
Indication •	 Need	for	an	Additional	Drug:	Untreated		indication
•	 Unclear	or	Unconfirmed	Indication:	Need	for	additional	diagnostic	test	and	review
•	 Unnecessary	Treatment:	No	appropriate	medical	indication;	therapeutic	or	
pharmacological duplication; drugs used for the treatment of avoidable adverse drug 
reactions (ADRs)
Effectiveness •	 Improper	Drug	Selection:	Drug	not	indicated	for	condition;	more	effective	drug	available;	
contraindication present
•	 Dosage	Too	Low	(Sub-therapeutic	Dose)
Safety •	 Dosage	Too	High	(Overdose)
•	 Risk	for	Adverse	reaction/s:	Unfavourable	safety	profile
•	 Risk	for	Drug-Drug	Interaction(s)
•	 Need	for	Monitoring
•	 Need	for	Counselling
•	 Need	for	Seamless	Care
Compliance •	 Inappropriate	compliance
Administration •	 Wrong	drug,	dose,	formulation	and/or	time	or	no	drug	administered
Table 1: Pharmaceutical care Issues classification at RhKg
RESuLTS 
Out of the 500 patient profiles reviewed in the study, there 
were 323 (64.6%) patients who had a pharmaceutical 
recommendation.	Out	of	these	patients,	26.9%	were	male	
(n=87)	and	73.1%	were	female	(n=236).	The	average	age	was	
80.3 years. Patients’ mean number of long-term medications 
was	8.59	with	a	median	of	8.	Orthopaedic	conditions	were	
the most common reason for admission, representing 
almost	 one	 third	 of	 all	 reasons	 for	 admission	 (n=96).	 A	
total	 of	 1069	 valid	 pharmacist	 recommendations	 were	
obtained. Table 2 shows the distribution of pharmacists’ 
recommendations. 
8Recommendation Example
need for Additional Drug
(n=339)	31.7	%
Heart failure; patient needs ACE inhibitor therapy
need for monitoring 
(n=155)	14.5%
Monitor liver function tests every six months in patient on amiodarone
Dosage Too high 
(n=119	)	11.2%
Decrease dose of bendroflumethiazide prescribed for 
hypertension to 2.5mg daily (from 5mg daily)
Risk for Adverse Reaction
(n=90	)	8.55%
Change perindopril in patients with persistent dry cough to valsartan
Dosage Too Low
(n=67	)	6.26%
Change dipyridamole 25mg tds to 100mg tds
Risk for Drug-Drug Interaction
(n=38	)	3.60%
Ciprofloxacin in patient with warfarin therapy
counseling need
(n=38)	3.60%
Patient on inhaler treatment
Improper Drug selection 
(n=37)	3.46%
Sedentary patients on nitrates with hypotension
Wrong	Drug,	Dose,	Formulation	and/or	Time	
(n=25)	2.33%
Change IV antibiotics to oral formulation
seamless care 
(n=14)	1.40%
Advising nursing home to make sure that patient takes alendronic acid with 
plenty of water while sitting or standing, at least 30 minutes before breakfast
contraindication Present
(n=9)	0.84%
Change amlodipine to ACE inhibitor in hypertensive patient with diabetes
Inappropriate compliance 
(n=6)	0.56%
Patient is using wrong inhaler technique, in which case the 
pharmacist would explain how to use the device
Unclear/Unconfirmed	Indication
(n=5)	0.46%
Patient on omeprazole with no bleeding risk
Table 2: Distribution of the Pharmacist Recommendation by category Type
The percentage of patients receiving a recommendation 
in this study was 64.6% (n=323) with a mean 
of 2.14 recommendations per patient.
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On	 follow	 up	 of	 the	 1069	 recommendations,	 77%	 were	
accepted	by	physicians	 (n=823),	19.2%	were	not	accepted	
(n=212)	 and	 3.5%	 (n=34)	 could	 not	 be	 evaluated	 for	
acceptance. All recommendation categories had a 
higher likelihood of being accepted rather than rejected. 
Recommendations classified as ‘need for monitoring’ had 
the	 highest	 percentage	 of	 acceptance	 with	 89.9%.	 The	
highest percentage of rejected recommendations was 
‘need	for	additional	drug’	with	27.7%.
DISCuSSION
This study evaluated the impact of the clinical pharmacy 
services at RhKg, by recording the type and number of 
pharmacist recommendations and the outcome. The 
percentage of patients receiving a recommendation 
in	 this	 study	 was	 64.6%	 (n=323)	 with	 a	 mean	 of	 2.14	
recommendations per patient. This observation is in 
agreement with the earlier study by Vella4	 in	2009,	carried	
out in the same setting. 
By reviewing the pharmacists’ recommendations 
documented, ‘need for additional drug’ was the most 
common intervention made by pharmacists in RhKg 
(31%), followed by ‘need for monitoring’ (14.5%) and 
‘dosage too high’ (11.2%). These results indicate that 
the pharmacists’ role in hospitals is very important 
in patients’ therapy and to provide advice to other 
healthcare professionals on the effects of medications. 
sellors et al. in 2003 reported that in a study carried out in 
a primary care setting, the addition of a medication is the 
most common recommendation.5
Physicians accepted advice on most of the recommendations 
proposed	 by	 pharmacists	 (77%).	 Possible	 reasons	 for	
not accepting the rejected recommendations are that a 
patient’s medication would have been commenced by a 
specialist and the physician would be reluctant to override 
the initial prescribing decision, or the physician might not 
consider the recommendation a priority. In a study by Ling 
in 2005, to evaluate clinical pharmacist involvement in 
the emergency department, the pharmacist’s advice was 
accepted	in	89%	of	cases.6
future studies could directly evaluate clinical improvement 
and medication effects including medication adherence or 
patient-relevant outcomes such as clinical status or quality of 
life measures arising from pharmacists’ recommendations. 
future work could also address cost-effectiveness of 
pharmacists’ recommendations through assessment of 
specific costs associated with each recommendation. This 
will enable the pharmacy department to demonstrate the 
importance of pharmaceutical care and the financial savings 
pharmacists can achieve. schumock et al in 2003 state that 
“for every $1 invested in clinical pharmacy services, $4 in 
benefit is expected.”7
CONCLuSION
The goal of this study was to record and evaluate the 
recommendations made by pharmacists in RhKg. The study 
provided several important insights. Pharmacists make 
many recommendations that affect the care of hospitalised 
patients, the most frequent of which were: ‘need for 
additional drug’, ‘Unnecessary Treatment’, and ‘Dosage too 
high’. Physicians accepted advice on the vast majority of 
recommendations proposed by pharmacists.
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Pharmacists make many recommendations that affect the care of 
hospitalised patients, the most frequent of which were: ‘Need for 
additional drug’, ‘Unnecessary Treatment’, and ‘Dosage too high’.
